From Basic Research to Cancer Drug: The Story of Cisplatin

if (n == null) The Scientist - From Basic Research to Cancer Drug: The Story of Cisplatin The Scientist 13[14]:11, Jul. 05, 1999 News From Basic Research to Cancer Drug: The Story of Cisplatin By Ricki Lewis Clinical Trial Results for Treating Cervical Cancer The April 15, 1999 issue of The New England Journal of Medicine (NEJM) brought great satisfaction to Barnett Rosenberg, a retired Michigan State University biophysicist who founded the Barros Resear

| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share


News

By Ricki Lewis

Clinical Trial Results for Treating Cervical Cancer

The April 15, 1999 issue of The New England Journal of Medicine (NEJM) brought great satisfaction to Barnett Rosenberg, a retired Michigan State University biophysicist who founded the Barros Research Institute in Holt, Mich., in 1982.1,2,3,4 Not many scientists can watch basic research blossom into a cancer treatment that has extended or saved thousands of lives. Rosenberg's keen observation in 1961 led, 18 years later, to Food and Drug Administration (FDA) approval of cisplatin. The drug's conception, gestation, and birth illustrate the scientific process and also the importance of following even the strangest of hunches.

Cisplatin revolutionized the treatment of testicular cancer, with success also against some ovarian and colon cancers. The trio of reports in the recent NEJM document remission in cervical cancer patients given cisplatin in combination with other treatments (See Box 1, in PDF file). ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Ricki Lewis

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio